Jan 04, 2018 12:01 pm UTC| Business
PRESS RELEASE Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors (Oxford, UK and Conshohocken, US, 4 January 2018) Immunocore Limited, the...
Inivata to present at the Biotech ShowcaseTM in San Francisco
Jan 04, 2018 12:01 pm UTC| Business
Inivata to present at the Biotech ShowcaseTM in San Francisco Company will also participate in "Generation Genome and Industrial Strategy: Leveraging UK Leadership in Genomics" Panel Research Triangle Park, NC...
Merus Provides Clinical Updates for MCLA-117 and MCLA-158 Programs
Jan 04, 2018 12:01 pm UTC| Business
- IND submitted to U.S. FDA for MCLA-117 in AML - - First CTA approval for MCLA-158 received in European country - UTRECHT, The Netherlands, Jan. 04, 2018 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage...
DSP Group Launches Major Push into Automotive Market with HearMeOut Partnership and IoT Products
Jan 04, 2018 12:01 pm UTC| Business
MILPITAS, Calif., Jan. 04, 2018 -- DSP Group®, Inc. (NASDAQ:DSPG) a leading global provider of wireless chipset solutions for converged communications, and HearMeOut Limited (ASX:HMO), a platform for voice-based social...
Dr. Stephen Gomes Joins Costas, Inc. as Chief Operating Officer (COO)
Jan 04, 2018 12:01 pm UTC| Business
LAS VEGAS, Jan. 04, 2018 -- via OTC PR WIRE -- Costas, Inc. (OTC.PK:CSSI) (OTC:CSSI) is pleased to welcome Dr. Stephen L. Gomes, president of Gomes and Company and former Business Professor at SUNY- Stony Brook- Korea...
WellCare Health Plans Selects VirtualHealth as its Care Management Platform
Jan 04, 2018 12:01 pm UTC| Business
NEW YORK, Jan. 04, 2018 -- VirtualHealth, the leading provider of population health and care management technologies, announced today that WellCare Health Plans, Inc. will deploy VirtualHealth’s nationally recognized...
BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.
Jan 04, 2018 12:01 pm UTC| Business
TORONTO, Jan. 04, 2018 -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of a letter of intent with RD Pharma (the...